位置:首页 > 蛋白库 > NMDE3_RAT
NMDE3_RAT
ID   NMDE3_RAT               Reviewed;        1237 AA.
AC   Q00961;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 1.
DT   03-AUG-2022, entry version 175.
DE   RecName: Full=Glutamate receptor ionotropic, NMDA 2C;
DE            Short=GluN2C;
DE   AltName: Full=Glutamate [NMDA] receptor subunit epsilon-3;
DE   AltName: Full=N-methyl D-aspartate receptor subtype 2C;
DE            Short=NMDAR2C {ECO:0000303|PubMed:8428958};
DE            Short=NR2C {ECO:0000303|PubMed:1350383};
DE   Flags: Precursor;
GN   Name=Grin2c;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=1350383; DOI=10.1126/science.256.5060.1217;
RA   Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomeli H.,
RA   Burnashev N., Sakmann B., Seeburg P.H.;
RT   "Heteromeric NMDA receptors: molecular and functional distinction of
RT   subtypes.";
RL   Science 256:1217-1221(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=8428958; DOI=10.1016/s0021-9258(18)53849-7;
RA   Ishii T., Moriyoshi K., Sugihara H., Sakurada K., Kadotani H., Yokoi M.,
RA   Akazawa C., Shigemoto R., Mizuno N., Masu M., Nakanishi S.;
RT   "Molecular characterization of the family of the N-methyl-D-aspartate
RT   receptor subunits.";
RL   J. Biol. Chem. 268:2836-2843(1993).
RN   [3]
RP   INTERACTION WITH DLG4.
RX   PubMed=7569905; DOI=10.1126/science.7569905;
RA   Kornau H.C., Schenker L.T., Kennedy M.B., Seeburg P.H.;
RT   "Domain interaction between NMDA receptor subunits and the postsynaptic
RT   density protein PSD-95.";
RL   Science 269:1737-1740(1995).
RN   [4]
RP   INTERACTION WITH PATJ.
RX   PubMed=9647694; DOI=10.1006/mcne.1998.0679;
RA   Kurschner C., Mermelstein P.G., Holden W.T., Surmeier D.J.;
RT   "CIPP, a novel multivalent PDZ domain protein, selectively interacts with
RT   Kir4.0 family members, NMDA receptor subunits, neurexins, and
RT   neuroligins.";
RL   Mol. Cell. Neurosci. 11:161-172(1998).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-912, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, AND MUTAGENESIS OF MET-815.
RX   PubMed=28126851; DOI=10.1124/mol.116.106781;
RA   Chen W., Tankovic A., Burger P.B., Kusumoto H., Traynelis S.F., Yuan H.;
RT   "Functional evaluation of a de novo GRIN2A mutation identified in a patient
RT   with profound global developmental delay and refractory epilepsy.";
RL   Mol. Pharmacol. 91:317-330(2017).
CC   -!- FUNCTION: Component of NMDA receptor complexes that function as
CC       heterotetrameric, ligand-gated ion channels with high calcium
CC       permeability and voltage-dependent sensitivity to magnesium. Channel
CC       activation requires binding of the neurotransmitter glutamate to the
CC       epsilon subunit, glycine binding to the zeta subunit, plus membrane
CC       depolarization to eliminate channel inhibition by Mg(2+)
CC       (PubMed:1350383, PubMed:8428958, PubMed:28126851). Sensitivity to
CC       glutamate and channel kinetics depend on the subunit composition
CC       (Probable). Plays a role in regulating the balance between excitatory
CC       and inhibitory activity of pyramidal neurons in the prefrontal cortex.
CC       Contributes to the slow phase of excitatory postsynaptic current, long-
CC       term synaptic potentiation, and learning (By similarity).
CC       {ECO:0000250|UniProtKB:Q01098, ECO:0000269|PubMed:1350383,
CC       ECO:0000269|PubMed:28126851, ECO:0000269|PubMed:8428958, ECO:0000305}.
CC   -!- SUBUNIT: Heterotetramer. Forms heterotetrameric channels composed of
CC       two zeta subunits (GRIN1), and two epsilon subunits (GRIN2A, GRIN2B,
CC       GRIN2C or GRIN2D) (in vitro) (PubMed:1350383, PubMed:8428958,
CC       PubMed:28126851). In vivo, the subunit composition may depend on the
CC       expression levels of the different subunits (Probable). Interacts with
CC       PDZ domains of PATJ and DLG4 (PubMed:7569905, PubMed:9647694).
CC       Interacts (via PDZ-binding motif) with SNX27 (via PDZ domain); the
CC       interaction is required for recycling to the plasma membrane when
CC       endocytosed and prevent degradation in lysosomes (By similarity).
CC       {ECO:0000250|UniProtKB:Q14957, ECO:0000269|PubMed:1350383,
CC       ECO:0000269|PubMed:28126851, ECO:0000269|PubMed:7569905,
CC       ECO:0000269|PubMed:8428958, ECO:0000269|PubMed:9647694, ECO:0000305}.
CC   -!- INTERACTION:
CC       Q00961; Q63ZW7: Patj; Xeno; NbExp=2; IntAct=EBI-631045, EBI-8366894;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:1350383,
CC       ECO:0000269|PubMed:28126851, ECO:0000269|PubMed:8428958}; Multi-pass
CC       membrane protein {ECO:0000250|UniProtKB:Q14957}. Postsynaptic cell
CC       membrane {ECO:0000250|UniProtKB:Q14957}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q14957}.
CC   -!- TISSUE SPECIFICITY: Detected in cerebellum.
CC       {ECO:0000269|PubMed:1350383, ECO:0000269|PubMed:8428958}.
CC   -!- DOMAIN: A hydrophobic region that gives rise to the prediction of a
CC       transmembrane span does not cross the membrane, but is part of a
CC       discontinuously helical region that dips into the membrane and is
CC       probably part of the pore and of the selectivity filter.
CC       {ECO:0000250|UniProtKB:Q00960}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC 1.A.10.1)
CC       family. NR2C/GRIN2C subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA02499.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M91563; AAA41713.1; -; mRNA.
DR   EMBL; D13212; BAA02499.1; ALT_INIT; mRNA.
DR   RefSeq; NP_036707.3; NM_012575.3.
DR   RefSeq; XP_006247769.1; XM_006247707.2.
DR   RefSeq; XP_006247771.1; XM_006247709.3.
DR   RefSeq; XP_017452475.1; XM_017596986.1.
DR   RefSeq; XP_017452476.1; XM_017596987.1.
DR   RefSeq; XP_017452477.1; XM_017596988.1.
DR   RefSeq; XP_017452478.1; XM_017596989.1.
DR   RefSeq; XP_017452479.1; XM_017596990.1.
DR   RefSeq; XP_017452480.1; XM_017596991.1.
DR   RefSeq; XP_017452481.1; XM_017596992.1.
DR   AlphaFoldDB; Q00961; -.
DR   SMR; Q00961; -.
DR   BioGRID; 246576; 6.
DR   ComplexPortal; CPX-287; NMDA receptor complex, GluN1-GluN2C.
DR   IntAct; Q00961; 5.
DR   MINT; Q00961; -.
DR   STRING; 10116.ENSRNOP00000004477; -.
DR   BindingDB; Q00961; -.
DR   ChEMBL; CHEMBL401; -.
DR   DrugCentral; Q00961; -.
DR   GuidetoPHARMACOLOGY; 458; -.
DR   GlyGen; Q00961; 6 sites.
DR   iPTMnet; Q00961; -.
DR   PhosphoSitePlus; Q00961; -.
DR   PaxDb; Q00961; -.
DR   PRIDE; Q00961; -.
DR   ABCD; Q00961; 3 sequenced antibodies.
DR   GeneID; 24411; -.
DR   KEGG; rno:24411; -.
DR   CTD; 2905; -.
DR   RGD; 2739; Grin2c.
DR   eggNOG; KOG1053; Eukaryota.
DR   InParanoid; Q00961; -.
DR   OrthoDB; 188544at2759; -.
DR   PhylomeDB; Q00961; -.
DR   TreeFam; TF314731; -.
DR   Reactome; R-RNO-438066; Unblocking of NMDA receptors, glutamate binding and activation.
DR   Reactome; R-RNO-8849932; Synaptic adhesion-like molecules.
DR   Reactome; R-RNO-9609736; Assembly and cell surface presentation of NMDA receptors.
DR   PRO; PR:Q00961; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0070161; C:anchoring junction; IEA:UniProtKB-KW.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISO:RGD.
DR   GO; GO:0017146; C:NMDA selective glutamate receptor complex; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0098839; C:postsynaptic density membrane; IBA:GO_Central.
DR   GO; GO:0045211; C:postsynaptic membrane; IC:ComplexPortal.
DR   GO; GO:0005261; F:cation channel activity; IDA:RGD.
DR   GO; GO:0022849; F:glutamate-gated calcium ion channel activity; ISS:UniProtKB.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; IDA:RGD.
DR   GO; GO:0015276; F:ligand-gated ion channel activity; IBA:GO_Central.
DR   GO; GO:0004972; F:NMDA glutamate receptor activity; IDA:RGD.
DR   GO; GO:0030165; F:PDZ domain binding; IPI:RGD.
DR   GO; GO:0047485; F:protein N-terminus binding; IPI:RGD.
DR   GO; GO:0038023; F:signaling receptor activity; IBA:GO_Central.
DR   GO; GO:1904315; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential; ISO:RGD.
DR   GO; GO:0097553; P:calcium ion transmembrane import into cytosol; ISS:UniProtKB.
DR   GO; GO:0033058; P:directional locomotion; ISO:RGD.
DR   GO; GO:0060079; P:excitatory postsynaptic potential; ISO:RGD.
DR   GO; GO:0035235; P:ionotropic glutamate receptor signaling pathway; IDA:ComplexPortal.
DR   GO; GO:0060291; P:long-term synaptic potentiation; IBA:GO_Central.
DR   GO; GO:0042177; P:negative regulation of protein catabolic process; ISO:RGD.
DR   GO; GO:0050885; P:neuromuscular process controlling balance; ISO:RGD.
DR   GO; GO:2000463; P:positive regulation of excitatory postsynaptic potential; IDA:ComplexPortal.
DR   GO; GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; IDA:ComplexPortal.
DR   GO; GO:1903539; P:protein localization to postsynaptic membrane; ISO:RGD.
DR   GO; GO:1904062; P:regulation of cation transmembrane transport; IDA:ComplexPortal.
DR   GO; GO:0042391; P:regulation of membrane potential; ISO:RGD.
DR   GO; GO:0048168; P:regulation of neuronal synaptic plasticity; IC:ComplexPortal.
DR   GO; GO:0009611; P:response to wounding; ISO:RGD.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001508; Iono_rcpt_met.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR018884; NMDAR2_C.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   Pfam; PF10565; NMDAR2_C; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
PE   1: Evidence at protein level;
KW   Calcium; Cell membrane; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Magnesium; Membrane;
KW   Phosphoprotein; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000255"
FT   CHAIN           20..1237
FT                   /note="Glutamate receptor ionotropic, NMDA 2C"
FT                   /id="PRO_0000011582"
FT   TOPO_DOM        20..554
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q00960"
FT   TRANSMEM        555..573
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:Q00960"
FT   TOPO_DOM        574..600
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q00960"
FT   INTRAMEM        601..620
FT                   /note="Discontinuously helical"
FT                   /evidence="ECO:0000250|UniProtKB:Q00960"
FT   TOPO_DOM        621..627
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q00960"
FT   TRANSMEM        628..643
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:Q00960"
FT   TOPO_DOM        644..814
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q00960"
FT   TRANSMEM        815..834
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:Q00960"
FT   TOPO_DOM        835..1237
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q00960"
FT   REGION          601..620
FT                   /note="Pore-forming"
FT                   /evidence="ECO:0000250|UniProtKB:Q00960"
FT   REGION          907..990
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           1235..1237
FT                   /note="PDZ-binding"
FT   COMPBIAS        907..936
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        937..952
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        967..981
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         509..511
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000250|UniProtKB:Q00959"
FT   BINDING         511
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000250|UniProtKB:Q00960"
FT   BINDING         516
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000250|UniProtKB:Q00959"
FT   BINDING         687..688
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000250|UniProtKB:Q00959"
FT   BINDING         729
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000250|UniProtKB:Q00960"
FT   SITE            612
FT                   /note="Functional determinant of NMDA receptors"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         875
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01098"
FT   MOD_RES         881
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01098"
FT   MOD_RES         912
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CARBOHYD        70
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        73
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        337
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        438
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        539
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        685
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        82..317
FT                   /evidence="ECO:0000250|UniProtKB:Q00959"
FT   DISULFID        426..453
FT                   /evidence="ECO:0000250|UniProtKB:Q00959"
FT   DISULFID        433..454
FT                   /evidence="ECO:0000250|UniProtKB:Q00959"
FT   DISULFID        743..798
FT                   /evidence="ECO:0000250|UniProtKB:Q00959"
FT   MUTAGEN         815
FT                   /note="M->V: Increased glutamate and glycine agonist
FT                   potency."
FT                   /evidence="ECO:0000269|PubMed:28126851"
SQ   SEQUENCE   1237 AA;  135271 MW;  B175993804B337A4 CRC64;
     MGGALGPALL LTSLLGAWAR LGAGQGEQAV TVAVVFGSSG PLQTQARTRL TSQNFLDLPL
     EIQPLTVGVN NTNPSSILTQ ICGLLGAARV HGIVFEDNVD TEAVAQLLDF VSSQTHVPIL
     SISGGSAVVL TPKEPGSAFL QLGVSLEQQL QVLFKVLEEY DWSAFAVITS LHPGHALFLE
     GVRAVADASY LSWRLLDVLT LELGPGGPRA RTQRLLRQVD APVLVAYCSR EEAEVLFAEA
     AQAGLVGPGH VWLVPNLALG STDAPPAAFP VGLISVVTES WRLSLRQKVR DGVAILALGA
     HSYRRQYGTL PAPAGDCRSH PGPVSPAREA FYRHLLNVTW EGRDFSFSPG GYLVRPTMVV
     IALNRHRLWE MVGRWDHGVL YMKYPVWPRY STSLQPVVDS RHLTVATLEE RPFVIVESPD
     PGTGGCVPNT VPCRRQSNHT FSSGDLTPYT KLCCKGFCID ILKKLAKVVK FSYDLYLVTN
     GKHGKRVRGV WNGMIGEVYY KRADMAIGSL TINEERSEII DFSVPFVETG ISVMVSRSNG
     TVSPSAFLEP YSPAVWVMMF VMCLTVVAIT VFMFEYFSPV SYNQNLTKGK KPGGPSFTIG
     KSVWLLWALV FNNSVPIENP RGTTSKIMVL VWAFFAVIFL ASYTANLAAF MIQEQYIDTV
     SGLSDKKFQR PQDQYPPFRF GTVPNGSTER NIRSNYRDMH THMVKFNQRS VEDALTSLKM
     GKLDAFIYDA AVLNYMAGKD EGCKLVTIGS GKVFATTGYG IAMQKDSHWK RAIDLALLQL
     LGDGETQKLE TVWLSGICQN EKNEVMSSKL DIDNMAGVFY MLLVAMGLAL LVFAWEHLVY
     WKLRHSVPNS SQLDFLLAFS RGIYSCFNGV QSLPSPARPP SPDLTADSAQ ANVLKMLQAA
     RDMVNTADVS SSLDRATRTI ENWGNNRRVP APTASGPRSS TPGPPGQPSP SGWGPPGGGR
     TPLARRAPQP PARPATCGPP LPDVSRPSCR HASDARWPVR VGHQGPHVSA SERRALPERS
     LLPAHCHYSS FPRAERSGRP YLPLFPEPPE PDDLPLLGPE QLARREAMLR AAWARGPRPR
     HASLPSSVAE AFTRSNPLPA RCTGHACACP CPQSRPSCRH LAQAQSLRLP SYPEACVEGV
     PAGVATWQPR QHVCLHAHTR LPFCWGTVCR HPPPCTSHSP WLIGTWEPPA HRVRTLGLGT
     GYRDSGVLEE VSREACGTQG FPRSCTWRRV SSLESEV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024